Cited by 250Influenza Virus Research StudiesRespiratory viral infections researchVaccine Coverage and Hesitancy

The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.

Effectiveness of influenza vaccines in preventing severe influenza illness among adults: A systematic review and meta- analysis of test-negative design case-control studies

Open access

Rondy, Marc, El Omeiri, Nathalie, Thompson, Mark G., Levêque, Alain, Moren, Alain, Sullivan, Sheena G.·2017·Journal of Infection

DOI 10.1016/j.jinf.2017.09.010PMC PMC5912669

Open this paper in CoChat — free account

Abstract

Objectives Summary evidence of influenza vaccine effectiveness (IVE) against hospitalized influenza is lacking. We conducted a meta-analysis of studies reporting IVE against laboratory-confirmed hospitalized influenza among adults.Methods We searched Pubmed (January 2009 to November 2016) for studies that used test-negative design (TND) to enrol patients hospitalized with influenza-associated conditions. Two independent authors selected relevant articles. We calculated pooled IVE against any and (sub)type specific influenza among all adults, and stratified by age group (18-64 and 65 years and above) using random-effects models.Results We identified 3411 publications and 30 met our inclusion criteria. Between 2010-11 and 2014-15, the pooled seasonal IVE was 41% (95%CI:34;48) for any influenza (51% (95%CI:44;58) among people aged 18-64y and 37% (95%CI:30;44) among ≥65 years). IVE was 48% (95%CI:37;59),37% (95%CI:24;50) and 38% (95%CI:23;53) against influenza A(H1N1)pdm09, A(H3N2) and B, respectively. Among persons aged ≥65 year, IVE against A(H3N2) was 43% (95%CI:33;53) in seasons when circulating and vaccine strains were antigenically similar and 14% (95%CI:-3;30) when A(H3N2) variant viruses predominated.Conclusions Influenza vaccines provided moderate protection against influenza-associated hospitalizations among adults. They seemed to provide low protection among elderly in seasons where vaccine and circulating A(H3N2) strains were antigenically variant.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.jinf.2017.09.010

Cites

85 of 85 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
Comparison of PubMed, Scopus, Web of Science, and Google Scholar: strengths and weaknesses
Falagas, M. E., Pitsouni, E. I., Malietzis, G. A., & Pappas, G. (2008) · The FASEB Journal · doi:10.1096/fj.07-9492lsf · Cited by 5,039
Prevention and Control of Influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Fiore, A. E., Shay, D. K., Broder, K. R., Iskander, J. K., Uyeki, T. M., Mootrey, G., Bresee, J. S., & Cox, N. S. (2001) · PsycEXTRA Dataset · doi:10.1037/e548312006-001 · Cited by 5,006
Investigating and dealing with publication and other biases in meta-analysis
Sterne, J. A. C., Egger, M., & Smith, G. D. (2001) · BMJ · doi:10.1136/bmj.323.7304.101 · Cited by 2,225
Vaccine hesitancy
Dubé, È., Laberge, C., Guay, M., Bramadat, P. A., Roy, R., & Bettinger, J. A. (2013) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.24657 · Cited by 2,178
The annual impact of seasonal influenza in the US: Measuring disease burden and costs
Molinari, N., Ortega‐Sanchez, I. R., Messonnier, M. L., Thompson, W., WORTLEY, P. M., Weintraub, E., & Bridges, C. B. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.03.046 · Cited by 1,722
Undue reliance on I 2 in assessing heterogeneity may mislead
Rücker, G., Schwarzer, G., Carpenter, J. R., & Schumacher, M. (2008) · BMC Medical Research Methodology · doi:10.1186/1471-2288-8-79 · Cited by 1,287
Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies
Belongia, E. A., Simpson, M. D., King, J. P., Sundaram, M. E., Kelley, N. S., Osterholm, M. T., & McLean, H. Q. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)00129-8 · Cited by 720

Show all 85 references

Research works printed but not linked: 1

World Health Organization, 2005, Influenza vaccines. WHO position paper, Wkly Epidemiol Rec, 80, 279

Sorted by citations

Items 101–200 of 250

Estimated Vaccine Effectiveness for Respiratory Syncytial Virus–Related Acute Respiratory Illness in Older Adults: Findings From the First Postlicensure Season
Tartof, S. Y., Aliabadi, N., Goodwin, G., Slezak, J. M., Hong, V. X., Ackerson, B. K., Liu, Q., Shaw, S. F., Welsh, S., Kapadia, B., et al. (2025) · Clinical Infectious Diseases · doi:10.1093/cid/ciaf496 · Cited by 13
Seasonal influenza vaccines: Variability of immune responses to B lineage viruses
Miller, M. S., Montomoli, E., Leshem, E., Schotsaert, M., Weinke, T., Vicic, N., & Rudin, D. (2024) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2024.2421096 · Cited by 13
Factors associated with perceptions of influenza vaccine safety and effectiveness among adults, United States, 2017–2018
Lutz, C. S., Fink, R. V., Cloud, A. J., Stevenson, J. F., Kim, D., & Fiebelkorn, A. P. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.12.004 · Cited by 13
Vaccine-induced protection in aging adults and pandemic response
Schenkelberg, T. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.10.090 · Cited by 11
Proficiency tests to evaluate the impact on assay outcomes of harmonized influenza-specific Intracellular Cytokine Staining (ICS) and IFN-ɣ Enzyme-Linked ImmunoSpot (ELISpot) protocols
Waerlop, G., Leroux-Roels, G. G., Pagnon, A., Begue, S., Salaun, B., Janssens, M., Medaglini, D., Pettini, E., Montomoli, E., Gianchecchi, E., et al. (2023) · Journal of Immunological Methods · doi:10.1016/j.jim.2023.113584 · Cited by 12
Association of vaccine awareness and confidence on the influenza vaccination status of Al Ahsa, Saudi Arabia residents
Al-Hassan, Y. T., Fabella, E. L., Estrella, E. D., Alramadan, H. A., Rajeh, A. M. A., & Saleh, F. H. A. (2021) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1855954 · Cited by 12
The Dutch influenza vaccination policy and medication use, outpatient visits, hospitalization and mortality at age 65
Ourti, T. V., & Bouckaert, N. (2020) · European Journal of Public Health · doi:10.1093/eurpub/ckaa016 · Cited by 11
Effectiveness of influenza vaccine in reducing influenza-associated hospitalizations and deaths among the elderly population; Lazio region, Italy, season 2016-2017
Fabiani, M., Volpe, E., Faraone, M., Bella, A., Pezzotti, P., & Chini, F. (2020) · Expert Review of Vaccines · doi:10.1080/14760584.2020.1750380 · Cited by 12
Impact of repeated yearly vaccination on immune responses to influenza vaccine in an elderly population
Kitamura, S., Matsushita, M., Komatsu, N., Yagi, Y., Takeuchi, S., & Seo, H. (2020) · American Journal of Infection Control · doi:10.1016/j.ajic.2020.05.011 · Cited by 11
Immune signature atlas of vaccines: learning from the good responders
Pedroza‐Pacheco, I., & McMichael, A. J. (2022) · Nature Immunology · doi:10.1038/s41590-022-01361-5 · Cited by 10
Effectiveness of inactivated influenza vaccine against laboratory-confirmed influenza among Chinese elderly: a test-negative design
Yang, T., Tang, L., Li, P., Li, B., Ye, L., & Zhou, J. (2024) · BMC Geriatrics · doi:10.1186/s12877-024-05003-3 · Cited by 11
Factors influencing the decision to receive seasonal influenza vaccination among US corporate non-healthcare workers
Aguolu, O. G., Willebrand, K. S., Elharake, J. A., Qureshi, H. M., Kiti, M. C., Liu, C. Y., Mesa, A. R., Nelson, K., Jenness, S. M., Melegaro, A., et al. (2022) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2022.2122379 · Cited by 11
Covid-19 and influenza vaccine effectiveness against associated hospital admission and death among individuals over 65 years in Norway: A population-based cohort study, 3 October 2022 to 20 June 2023
Seppälä, E. M., Dahl, J., Veneti, L., Rydland, K. M., Klüwer, B., Rohringer, A., & Meijerink, H. (2023) · Vaccine · doi:10.1016/j.vaccine.2023.12.050 · Cited by 11
Influenza update 2018–2019: 100 years after the great pandemic
Mossad, S. B. (2018) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.85a.18095 · Cited by 11
Impact of national influenza vaccination strategy in severe influenza outcomes among the high-risk Portuguese population
Machado, A., Kislaya, I., Larrauri, A., Dias, C. M., & Nunes, B. (2019) · BMC Public Health · doi:10.1186/s12889-019-7958-8 · Cited by 11
Effective Immunization of Older Adults Against Seasonal Influenza
Schaffner, W., Chen, W. H., HOPKINS, R. H., & Neuzil, K. M. (2018) · The American Journal of Medicine · doi:10.1016/j.amjmed.2018.02.019 · Cited by 13
Rationale and design of NUDGE-FLU-CHRONIC and NUDGE-FLU-2: Two nationwide randomized trials of electronic nudges to increase influenza vaccination among patients with chronic diseases and older adults during the 2023/2024 influenza season
Johansen, N. D., Vaduganathan, M., Bhatt, A. S., Modin, D., Chatur, S., Claggett, B. L., Janstrup, K. H., Larsen, C. S., Larsen, L., Wiese, L., et al. (2024) · American Heart Journal · doi:10.1016/j.ahj.2024.03.003 · Cited by 11
Uptake and correlates of influenza vaccine among older adults residing in rural regions of south China: a cross-sectional study
Zhao, P., Xu, W., Wang, J., Liang, P., Li, H., & Wang, C. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1383293 · Cited by 9
Hemagglutinin virus-like particles incorporated with membrane-bound cytokine adjuvants provide protection against homologous and heterologous influenza virus challenge in aged mice
Park, B. R., Bommireddy, R., Chung, D. H., Kim, K., Subbiah, J., Jung, Y., Bhatnagar, N., Pack, C. D., Ramachandiran, S., Reddy, S. J. C., et al. (2023) · Immunity & Ageing · doi:10.1186/s12979-023-00344-w · Cited by 9
Real-Time Spatiotemporal Analysis of Microepidemics of Influenza and COVID-19 Based on Hospital Network Data: Colocalization of Neighborhood-Level Hotspots
Mylona, E. K., Shehadeh, F., Kalligeros, M., Benitez, G., Chan, P. A., & Mylonakis, E. E. (2020) · American Journal of Public Health · doi:10.2105/ajph.2020.305911 · Cited by 9
COVID-19 related interdisciplinary methods: Preventing errors and detecting research opportunities
Rivas, A. L., & Regenmortel, M. H. V. V. (2021) · Methods · doi:10.1016/j.ymeth.2021.05.014 · Cited by 10
Influenza vaccine effectiveness within prospective cohorts of healthcare personnel in Israel and Peru 2016–2019
Thompson, M. G., Soto, G. M., Peretz, A., Newes‐Adeyi, G., Yoo, Y. M., Hirsch, A., Katz, M. A., Tinoco, Y. O., Avni, Y. S., Ticona, E., et al. (2021) · Vaccine · doi:10.1016/j.vaccine.2021.07.077 · Cited by 8
Validation of International Classification of Diseases criteria to identify severe influenza hospitalizations
Snyder, B. M., Patterson, M. F., Gebretsadik, T. S., Wu, P., Ding, T., Lee, R. L., Edwards, K. M., Somerville, L., Braciale, T. J., Ortiz, J. R., et al. (2022) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12931 · Cited by 8
Effectiveness of influenza vaccination in infants and toddlers with and without prior infection history: The Japan Environment and Children’s Study
Yokomichi, H., Kojima, R., Horiuchi, S., Ooka, T., Akiyama, Y., Miyake, K., Mochizuki, M., Otawa, S., Shinohara, R., & Yamagata, Z. (2021) · Vaccine · doi:10.1016/j.vaccine.2021.02.044 · Cited by 8
Factors Associated with Influenza Vaccination Among Urban Community-Dwelling Chinese Elderly: Results from a Multicity Cross-Sectional Study
Guo, J., Jiao, X., Yuan, S., & You, L. (2025) · Vaccines · doi:10.3390/vaccines13111171 · Cited by 7
Immunogenicity and safety of quadrivalent influenza vaccine among young and older adults in Tianjin, China: implication of immunosenescence as a risk factor
Xiao, T., Wei, M., Guo, X., Zhang, Y., Wang, Z., Xia, X., Qi, X., Wang, L., Li, X., & Leng, S. X. (2023) · Immunity & Ageing · doi:10.1186/s12979-023-00364-6 · Cited by 7
Design of peptide epitope from the neuraminidase protein of influenza A and influenza B towards short peptide vaccine development
Sankar, S., Ramamurthy, M., Suganya, S., Nandagopal, B., & Sridharan, G. (2018) · Bioinformation · doi:10.6026/97320630014183 · Cited by 7
Endoplasmic reticulum stress response and bile acid signatures associate with multi-strain seroresponsiveness during elderly influenza vaccination
Carré, C., Wong, G. C. L., Narang, V., Tan, C. T., Chong, J., Chin, H. X., Xu, W., Lu, Y., Chua, M., Poidinger, M., et al. (2021) · iScience · doi:10.1016/j.isci.2021.102970 · Cited by 7
Adverse outcomes in patients hospitalized with pneumonia at age 60 or more: A prospective multi-centric hospital-based study in India
Kanungo, S., Bhattacharjee, U., Prabhakaran, A. O., Kumar, R., Rajkumar, P., Bhardwaj, S. D., Chakrabarti, A. K., Kumar, C. P. G., Potdar, V. A., Manna, B., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0297452 · Cited by 6
Antineuraminidase Antibody Responses in Older Adults After Consecutive Vaccinations With Enhanced Influenza Vaccines: A Randomized Controlled Trial
Daulagala, P., Leung, Y. W. Y., Luk, L. L. H., Ho, F. C. S., Chu, S. H. N., Lin, J., Cheng, S. M. S., Leung, N., Eichelberger, M. C., Peiris, M. J. S., et al. (2025) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaf616 · Cited by 7
Eficacia, efectividad y seguridad de la vacuna antigripal adyuvada en población de 65 o más años de edad
Martínez, M., Bouza, J., Rubió, P. P., Puig-Barberà, J., Aragón, J., & Lana, Á. T. (2023) · Revista Espanola de Quimioterapia · doi:10.37201/req/145.2022 · Cited by 6
High-dose trivalent influenza vaccine. Efficacy and effectiveness
de Miguel, Á. G., Margüello, E. R., Díez‐Domingo, J., de Lejarazu, R. O., Martinón‐Torres, F., & Departamento de Medicina Preventiva y Salud Pública, U. R. J. C. (2020) · Revista Española de Quimioterapia · doi:10.37201/req/043.2020 · Cited by 6
Antibody response to sequential vaccination with cell culture, recombinant, or egg-based influenza vaccines among U.S. adults
Boyce, T. G., Levine, M. Z., McClure, D. L., King, J. P., Flannery, B. L., Nguyen, H. Q., & Belongia, E. A. (2024) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2024.2370087 · Cited by 5
Influenza vaccine effectiveness over 17 seasons in a large Japanese cohort: Analyses by age, virus type, underlying diseases and seasons before the COVID-19 pandemic
Kawai, N., Ikematsu, H., Bando, T., Kawashima, T., Matsuura, S., Maeda, T., Lee, W. J., Nagao, S., Yoshimura, M., Mori, K., et al. (2025) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2025.102934 · Cited by 6
COVID-19 Vaccination Strategies in the Endemic Period: Lessons from Influenza
Nham, E., Noh, J. Y., Park, O. H., Choi, W. S., Song, J. Y., Cheong, H. J., & Kim, W. J. (2024) · Vaccines · doi:10.3390/vaccines12050514 · Cited by 6
How Drivers of Seasonality in Respiratory Infections May Impact Vaccine Strategy: A Case Study in How Coronavirus Disease 2019 (COVID-19) May Help Us Solve One of Influenza’s Biggest Challenges
Lofgren, E., Naumova, E. N., Gorski, J., Naumov, Y. N., & Fefferman, N. H. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac400 · Cited by 5
Overcoming Aging-Associated Poor Influenza Vaccine Responses with CpG 1018 Adjuvant
Kang, X., Li, Y., Zhao, Y., & Chen, X. (2022) · Vaccines · doi:10.3390/vaccines10111894 · Cited by 5
Influenza disease burden and the need for highly immunogenic vaccines in older adults: a narrative review
Song, J. Y. (2024) · Ewha Medical Journal · doi:10.12771/emj.2024.e35 · Cited by 5
Seasonal influenza vaccination rate and vaccine effectiveness among older adults in mainland China: a systematic review and meta-analysis
Ma, R., Du, Y., Jing, W., Ma, H., Wang, K., Liu, A., Chen, S., Zhou, M., Zhou, Y., Su, S., et al. (2025) · Age and Ageing · doi:10.1093/ageing/afaf252 · Cited by 4
Influenza vaccination in older adults: integral to good geriatric care
Veronese, N., Soiza, R. L., & Michel, J. (2025) · Age and Ageing · doi:10.1093/ageing/afaf365 · Cited by 4
Effectiveness of vaccination on influenza-related critical illnesses in the elderly population
Aso, S., Ono, S., Michihata, N., Uemura, K., & Yasunaga, H. (2023) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2023.02.002 · Cited by 4
Projecting influenza vaccine effectiveness: A simulation study
VILCHES, T. N., Shoukat, A., Ferreira, C. P., & Moghadas, S. M. (2020) · PLoS ONE · doi:10.1371/journal.pone.0241549 · Cited by 4
Vaccination in old age: Challenges and promises
Caruso, C., Aiello, A., Pawelec, G., & Ligotti, M. E. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822569-1.00020-2 · Cited by 4
Journal of Preventive Medicine and Hygiene, Vol. 63 No. 4S1 (2022): L’Health Technology Assessment come strumento value-based per la valutazione delle tecnologie sanitarie. Reassessment del vaccino antinfluenzale quadrivalente da coltura cellulare: Flucelvax Tetra® 2.0
Hygiene, J. O. P. M. A. (2023) · PubMed Central · doi:10.15167/2421-4248/jpmh2022.63.4s1 · Cited by 4
Influenza vaccine effectiveness against hospitalization with laboratory-confirmed influenza in Greece: A pooled analysis across six seasons, 2013–2014 to 2018–2019
Mouratidou, E., Lambrou, A., Andreopoulou, A., Gioula, G., Exindari, M., Kossyvakis, A., Pogka, V., Mentis, A. F., Georgakopoulou, T., & Lytras, T. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.01.083 · Cited by 4
Differential Influence of Age on the Relationship between Genetic Mismatch and A(H1N1)pdm09 Vaccine Effectiveness
Cao, L., Zhao, S., Lou, J., Zheng, H., Chan, R. W. Y., Chong, K. C., Chen, Z., Chan, P. K. S., Zee, B. C.-Y., & Wang, M. H. (2021) · Viruses · doi:10.3390/v13040619 · Cited by 4
The effect of pharmacists as vaccinators on uptake of influenza vaccination in Denmark: An interrupted time series analysis
Williams, A. L., Musse, I., Mitrovich, R., Shanmugam, P., Vohra, D., Lansdale, A. J., Benčina, G., Fevre, T. L., & Eiden, A. L. (2025) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2025.06.100 · Cited by 3
Update on Influenza
Hannaford, A., Aleissa, M. M., & Sherman, A. C. (2025) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2025.10.010 · Cited by 4
IAPSM’s Position Paper on Influenza Vaccines for Adult Immunization in India
Sharma, N., Verma, M., Goel, K., Kulkarni, M. M., Bhardwaj, A., Sharma, S., Singh, T., Gupta, M., Nadda, A., & Sankhe, L. (2024) · Indian Journal of Community Medicine · doi:10.4103/ijcm.ijcm_741_24 · Cited by 3
Simultaneous Influenza Vaccination and Hymenoptera Venom Immunotherapy Is Safe
Czerwińska, E., Nittner‐Marszalska, M., Pawłowicz, R., & Szenborn, L. (2021) · Vaccines · doi:10.3390/vaccines9040344 · Cited by 3
Projected impact of a plant-derived vaccine on the burden of seasonal influenza in Canada
Ramjee, L., Lemay, W., Vurgun, N., Charland, N., Bauch, C. T., Pullagura, G. R., Houle, S. K. D., & Tremblay, G. (2021) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2021.1908797 · Cited by 3
Decreased vaccine protection of egg-based influenza vaccine in the elderly and nonhemagglutinin-focused immunity
Gonzalez, K. J., & Strauch, E. (2021) · Journal of Clinical Investigation · doi:10.1172/jci151732 · Cited by 3
Reciprocal relationships among influenza experiences, perceptions, and behavior: Results from a national, longitudinal survey of United States adults
Nowak, S. A., Parker, A. M., Gidengil, C. A., Richardson, A. S., Walsh, M. M., Kennedy, D. P., & Vardavas, R. (2022) · Social Science & Medicine · doi:10.1016/j.socscimed.2021.114693 · Cited by 3
Comparison of COVID-19 and seasonal influenza under different intensities of non-pharmaceutical interventions and vaccine effectiveness
Chen, Y., Wang, Z., Li, F., Ma, J., Zhang, J., Chen, Y., & Zhang, T. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.973088 · Cited by 3
A phase I study of the safety, reactogenicity and immunogenicity of two quadrivalent seasonal influenza vaccines (Fluzone® or Flublok®) with or without one of two adjuvants (AF03 or Advax-CpG55.2) in healthy adults 18–45 years of age
Hegmann, T. E., Walter, E. B., Smith, M. J., Campbell, J., Sahly, H. M. E., Whitaker, J. A., Creech, C. B., Ustyugova, I. V., Goncalvez, A. P., Pandey, A., et al. (2025) · Vaccine · doi:10.1016/j.vaccine.2025.126991 · Cited by 3
Effectiveness of a theory-informed intervention to increase care home staff influenza vaccination rates: a cluster randomised controlled trial
Wright, D. J., Blacklock, J., Bion, V., Birt, L., Clark, A., Griffiths, A. W., Guillard, C., Stirling, S., Jones, A., Holland, R., et al. (2025) · Journal of Public Health · doi:10.1093/pubmed/fdaf023 · Cited by 3
Influenza Vaccine Effectiveness in Australia During 2017–2019
Diefenbach-Elstob, T. R., Chilver, M. B.-N., Spirkoska, V., Carville, K. S., Dapat, C., Turra, M., Tran, T., Deng, Y., Peck, H., Barr, I., et al. (2025) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.70137 · Cited by 3
Implementing an Influenza Vaccine Effectiveness Study in a Hospital Context in Portugal: The EVA Hospital Project
Machado, A., Gomez, V., Panarra, A., Poças, J., Côrte‐Real, R., Peres, M. J., & Nunes, B. (2020) · Acta Médica Portuguesa · doi:10.20344/amp.13438 · Cited by 3
Impact of influenza vaccination in the Netherlands, 2007–2016: Vaccinees consult their general practitioner for clinically diagnosed influenza, acute respiratory infections, and pneumonia more often than non-vaccinees
Caini, S., Paget, J., Spreeuwenberg, P. M. M., Korevaar, J. C., Meijer, A., & Hooiveld, M. (2021) · PLoS ONE · doi:10.1371/journal.pone.0249883 · Cited by 3
Methodological and organizational approaches of involving pharmacists in the vaccination against influenza strategy for patients with diabetes
Власенко, І. О., & Давтян, Л. Л. (2022) · Fìtoterapìâ · doi:10.33617/2522-9680-2022-4-107 · Cited by 2
Influenza
KILIÇ, E. K., & Ünal, S. (2023) · Flora the Journal of Infectious Diseases and Clinical Microbiology · doi:10.5578/flora.20239601 · Cited by 2
Clinical predictors of severe forms of influenza A(H1N1)pdm09 in adults and children during the 2009 epidemic in Brazil
Braga, J. U. (2024) · PLoS ONE · doi:10.1371/journal.pone.0291843 · Cited by 2
A Call for Adopting High-Dose Influenza Vaccines for Adults Aged 65 and Above in Gulf Cooperation Council (GCC) Countries
Awaidy, S. T. A., Koul, P. A., Khamis, F. A., Slil, F. A., Jroundi, I., Olama, F. A., Elawad, K. H., Abuhasan, M. Y., Oraimi, F. A., Tanrıöver, M. D., et al. (2024) · Journal of Epidemiology and Global Health · doi:10.1007/s44197-024-00292-8 · Cited by 2
High-dose influenza vaccine: enhanced protection for the elderly
Trombetta, C. M., & Montomoli, E. (2025) · Expert Review of Vaccines · doi:10.1080/14760584.2025.2596673 · Cited by 2
Effect of high-dose versus standard-dose influenza vaccines on hospitalisation outcomes and mortality in older adults: a systematic review and meta-analysis
Zhao, W., Lian, R., Zhao, Y., Li, Z., Liu, M., Yang, F., Zhang, J., Tian, J., Xue, F., & Gao, Y. (2026) · The Lancet Healthy Longevity · doi:10.1016/j.lanhl.2026.100870 · Cited by 2
A hospital-based nonconcurrent cohort study on factors associated with in-hospital mortality in patients with laboratory confirmed influenza
Alexander, V., Paul, G. J. S., Zachariah, A., & Mathuram, A. J. (2020) · Journal of Global Infectious Diseases · doi:10.4103/jgid.jgid_45_20 · Cited by 3
Clinical diagnosis of seasonal influenza by physicians: a retrospective observational study
Maita, H., Kobayashi, T., Akimoto, T., Matsuoka, F., Funakoshi, S., Osawa, H., & Kato, H. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-055910 · Cited by 2
Characteristics and methodological standards across systematic reviews with Meta-analysis of efficacy and/or effectiveness of influenza vaccines: an overview of reviews
Okoli, G. N., Reddy, V. K., Lam, O., Racovitan, F., Al‐Yousif, Y., & Askin, N. (2022) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2022.2114537 · Cited by 2
Attributes of pharmacy's educational activities according to good pharmacy practice standards from the perspective of patients with diabetes
Власенко, І. О., & Давтян, Л. Л. (2023) · Farmatsevtychnyi zhurnal · doi:10.32352/0367-3057.1.23.04 · Cited by 2
Inactivated and Recombinant Influenza Vaccines
Patel, M. M., Grohskopf, L. A., Sambhara, S. R., Belser, J. A., Katz, J. M., & Fry, A. M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-79058-1.00033-5 · Cited by 2
Estimates of Seasonal Influenza Burden That Could Be Averted by Improved Influenza Vaccines in the Australian Population Aged Under 65 Years, 2015–2019
Stein, A., Pendrey, C. G. A., Muscatello, D. J., Buynder, P. G. V., Fielding, J., Menche, J., & Sullivan, S. G. (2024) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.13289 · Cited by 2
Promoting aged care COVID-19 and influenza vaccination through education of Australian residential aged care staff: A mixed methods project evaluation
Tranter, I., Judd, D., Stickley, M., Vasant, B. R., Pollard, G., Swindells, C., & Anuradha, S. (2025) · Vaccine · doi:10.1016/j.vaccine.2025.126742 · Cited by 2
Influenza Vaccine-Averted Illness in Chile, Guyana, and Paraguay During 2013–2018: A Standardized Approach to Assess the Value of Vaccination
Jara, J., Loayza, S., Nogareda, F., Couto, P., Descalzo, M. Á., Chard, A. N., Olivares, M. F., Vergara, N., Fasce, R., Horoch, M. V., et al. (2025) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaf038 · Cited by 2
A Retrospective Test-Negative Case-Control Study to Evaluate Influenza Vaccine Effectiveness in Preventing Influenza Among Immunocompromised Adults With a Solid Organ Transplant
Prins, M. L. M., van Dokkum, E. D., de Vries, A. P. J., Tushuizen, M. E., van der Helm, D., Spithoven, E. M., van der Meer, I. M., Groeneveld, J. H. M., Visser, L. G., le Cessie, S., et al. (2025) · Transplant International · doi:10.3389/ti.2025.14187 · Cited by 2
Effectiveness of influenza vaccination
Hristu, E., & Bucur, L. E. (2019) · Farmacist ro · doi:10.26416/farm.186.1.2019.2255 · Cited by 2
Vaccin grippal haute dose : un vaccin adapté aux 65 ans et plus
Gavazzi, G., Mosnier, A., Crépey, P., & Gaillat, J. (2022) · La Presse Médicale Formation · doi:10.1016/j.lpmfor.2022.01.001 · Cited by 1
Improving Influenza Vaccination Rates in an Underserved Primary Care Clinic Using a Simple Educational Tool
Baltes, M., Pronovost, E., Kanuch, S. W., & Caron, A. (2022) · Quality Management in Health Care · doi:10.1097/qmh.0000000000000335 · Cited by 2
Age-dependent and sex-dependent differences in mortality from influenza-associated cardiovascular diseases among older adults in Shanghai, China: a population-based study
Jin, S., Jiang, C., Xia, T., Gu, Z. Y., Yu, H., Li, J., Zheng, Y., Pān, H., Qiao, J., Cai, R., et al. (2022) · BMJ Open · doi:10.1136/bmjopen-2022-061068 · Cited by 2
Patient Portal Reminders—Easy but Ineffective
Judson, T. J., & Gonzales, R. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2020.1589 · Cited by 2
Employee Health and Firm PerformancePreprint
Rettl, D. A., Schandlbauer, A., & Trandafir, M. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4022672 · Cited by 2
Employee Health and Firm PerformancePreprint
Rettl, D. A., Schandlbauer, A., & Trandafir, M. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4114706 · Cited by 2
Winter viruses: we can do more to prevent a surge in cases
Broadbent, L. (2025) · BMJ · doi:10.1136/bmj.r77 · Cited by 2
Obesity, inflammation, and aging
Chu, J. J., & Mehrzad, R. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90960-0.00001-1 · Cited by 1
Influenza vaccine viruses and the development of seasonal vaccines: A Japanese perspective
Kato, H., Hozawa, T., Fukushima, W., Nobusawa, E., & Hirota, Y. (2023) · Vaccine · doi:10.1016/j.vaccine.2023.05.070 · Cited by 1
Influenza Vaccine Effectiveness against Hospitalization, Season 2021/22: A Test-Negative Design Study in Barcelona
Fornaguera, M., Parés‐Badell, O., Carbonés-Fargas, Í., Andrés, C., Rodrigo‐Pendás, J. Á., Borràs-Bermejo, B., Armadans, L., Tejada, G., Guananga-Álvarez, D., Vivet-Escalé, M., et al. (2023) · Vaccines · doi:10.3390/vaccines11091450 · Cited by 1
The optimal strategy for seasonal influenza vaccination to prevent high-intensity level of influenza epidemics in Zhejiang, China: an integrated transmission-dynamic and health-economic modeling analysis
Chen, M., Yang, M., Yan, R., Liu, Z., Chen, C., Qu, R., Zhou, W., Qi, J., Cao, K., Miao, J., et al. (2025) · BMC Public Health · doi:10.1186/s12889-025-23648-6 · Cited by 1
Vaccination for Older Adults in India: Position Statement of the Indian Academy of Geriatrics
Singhal, S., Dewangan, G. C., Mehta, P. K., Viggeswarpu, S., Dey, A. B., & Gunasekaran, V. (2026) · Journal of The Indian Academy of Geriatrics · doi:10.4103/jiag.jiag_42_26 · Cited by 1
Clinical and Economic Inpatient Burden of Influenza and Influenza-Like Illness in Germany 2019–2025: Analysis of Nationwide Hospital Data
Meyer, A. C., Kiesel, S., Poshtiban, A., Wick, M., & Damm, O. (2026) · Infectious Diseases and Therapy · doi:10.1007/s40121-026-01384-7 · Cited by 1
Right sizing for vaccine effectiveness studies: how many is enough for reliable estimation?
Price, O. H., Carville, K. S., & Sullivan, S. G. (2019) · Communicable Diseases Intelligence · doi:10.33321/cdi.2019.43.20 · Cited by 1
Talking to Patients about the Influenza Vaccine.
Byrd, K. M. (2020) · PubMed · Cited by 1
Optimizing mood prior to influenza vaccination in older adults: A three-arm randomized controlled trial.
Ayling, K., Brown, M., Carlisle, S., Bennett, R. W., Buchanan, H., Dumbleton, J., Hawkey, C. J., Höschler, K., Jack, R. H., Nguyen‐Van‐Tam, J. S., et al. (2023) · Health Psychology · doi:10.1037/hea0001267 · Cited by 1
A clinical and economic assessment of adjuvanted trivalent versus standard egg-derived quadrivalent influenza vaccines among older adults in the United States during the 2018-19 and 2019-20 influenza seasons
Levin, M. J., Divino, V. M., Postma, M. J., Pelton, S. I., Zhou, Z., DeKoven, M., & Mould-Quevedo, J. F. (2023) · Expert Review of Vaccines · doi:10.1080/14760584.2023.2293237 · Cited by 2
Towards better protection of older people against influenza and its complications. Polish recommendations for HD influenza vaccine
Nitsch-Osuch, A. S., Jankowski, P., Kokoszka-Paszkot, J., Kuchar, E. P., Mastalerz–Migas, A., Mitkowski, P. P., Wysocki, J., Zmysłowska, A., & Antczak, A. J. (2024) · Family Medicine & Primary Care Review · doi:10.5114/fmpcr.2024.134715 · Cited by 2
A combined approach maximises vaccination rates in older people—health education, centralised reminders and onsite vaccination
Soiza, R. L., & Khan, Z. A. (2024) · Age and Ageing · doi:10.1093/ageing/afae060 · Cited by 1
Effectiveness of Text Messaging Nudging to Increase Coverage of Influenza Vaccination Among Older Adults in Norway (InfluSMS Study): Protocol for a Randomized Controlled Trial
Hansen, B. T., Klungsøyr, O., Labberton, A. S., Sääksvuori, L., Rydland, K. M., Ødeskaug, L. E., Wisløff, T. F., & Meijerink, H. (2024) · JMIR Research Protocols · doi:10.2196/63938 · Cited by 1
MF59-like adjuvant containing yeast-derived squalene enhances the humoral immune response to cell-derived influenza vaccine
Chen, T., Xu, W., Duan, P., Jiang, S.-J., Yang, X., Cao, H., Zheng, M., & Luo, J. (2025) · Archives of Virology · doi:10.1007/s00705-025-06306-5 · Cited by 1
How are sociodemographic factors associated with 2020/2021 seasonal influenza vaccination behavior under the COVID-19 pandemic?Preprint
Mori, T., Nagata, T., Ikegami, K., Hino, A., Tateishi, S., Tsuji, M., Matsuda, S., Fujino, Y., Mori, K., & the CORoNaWork project (2021) · medRxiv · doi:10.1101/2021.04.30.21256364 · Cited by 1
I (Influenza) will be back!
Lina, B. (2018) · Anaesthesia Critical Care & Pain Medicine · doi:10.1016/j.accpm.2017.12.008
How effective is the influenza vaccine in preventing influenza in adults?
Weeks, J., Clements, E., Iles, A. M., Hicks, C., & Hurst, D. J. (2020) · Evidence-Based Practice · doi:10.1097/ebp.0000000000000450
Influenza Vaccine Efficacy/Effectiveness: With Special Reference to Current Epidemiological Methodology
Fukushima, W. (2020) · Respiratory disease series · doi:10.1007/978-981-15-9109-9_20

Authors: Rondy, M., El Omeiri, N., Thompson, M. G., Levêque, A., Moren, A., & Sullivan, S. G.
Affiliations: Université de Bordeaux (FR)
Centers for Disease Control and Prevention (US)
Peter Doherty Institute (AU)
Corresponding author: Rondy, Marc
ORCID: Rondy, Marc
Thompson, Mark G.
Moren, Alain
Sullivan, Sheena G.
Venue: Journal of Infection
Publisher: Elsevier BV
Published: 2017-11
Volume: 75
Issue: 5
Pages: 381-394
ISSN: 0163-4453 (ISSN-L)
DOI: 10.1016/j.jinf.2017.09.010
PMC: PMC5912669
OpenAlex: W2754200907
Cited by: 247
References: 85
Citations by year: 2026: 20 · 2025: 31 · 2024: 29 · 2023: 34 · 2022: 30 · 2021: 35 · 2020: 38 · 2019: 16 · 2018: 13 · 2017: 1
FWCI: 2.46
Type: journal article
Language: en
Open access: green
europepmc.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: Journal of Infection (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
Funders: National Institutes of Health (CC999999)
Topics: Health Sciences › Medicine › Epidemiology › Influenza Virus Research Studies
Health Sciences › Medicine › Epidemiology › Respiratory viral infections research
Social Sciences › Health › Vaccine Coverage and Hesitancy
Keywords: influenza vaccine effectiveness, seasonal influenza vaccine, influenza-associated hospitalizations, test-negative design, influenza A(H1N1)pdm09, H3N2, influenza B, antigenic mismatch, older adults, adults
MeSH terms: Immunogenicity, Vaccine, Adult, Hospitalization, Humans, Influenza, Human, Influenza Vaccines, Case-Control Studies, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Effectiveness of influenza vaccines in preventing severe influenza illness among adults: A systematic review and meta- analysis of test-negative design case-control studies

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks